Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Woodruff

Showing results (391-400 of 443) with videos related to

Pageof 45
Sort By:
British Journal of Pharmacology|April 27, 2025
Colon-targeted complement C5a<sub>1</sub> receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitisCedric S Cui, Titaya Lerskiatiphanich, Xaria X Li, et al.
Clinical and Experimental Immunology|November 17, 2018
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4A Landsem, H Fure, J Krey Ludviksen, et al.
Immunology and Cell Biology|April 26, 2016
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signallingDaniel E Croker, Peter N Monk, Reena Halai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2019
Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue FactorCaroline S Gravastrand, Bjørg Steinkjer, Bente Halvorsen, et al.
Nature Communications|October 6, 2016
Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degenerationRichard Gordon, Matthew L Neal, Jie Luo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegenerationTrent M Woodruff, James W Crane, Lavinia M Proctor, et al.
Archives of Pathology & Laboratory Medicine|January 1, 1997
Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer InstituteJ Albores-Saavedra, D Gersell, C B Gilks, et al.
Glia|October 10, 2019
The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteinsVandana Deora, John D Lee, Eduardo A Albornoz, et al.
Acta Neuropathologica|January 29, 2000
Schwann cell-onion bulb tumor of the trigeminal nerve: hyperplasia, dysplasia or neoplasia?S F LaPoint, J M Powers, J M Woodruff, et al.
Molecular Pharmacology|March 27, 2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activityDarren R March, Lavinia M Proctor, Martin J Stoermer, et al.
Pageof 45

Showing results (391-400 of 443) with videos related to

Sort By:
Pageof 45
British Journal of Pharmacology|April 27, 2025
Colon-targeted complement C5a<sub>1</sub> receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitisCedric S Cui, Titaya Lerskiatiphanich, Xaria X Li, et al.
Clinical and Experimental Immunology|November 17, 2018
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4A Landsem, H Fure, J Krey Ludviksen, et al.
Immunology and Cell Biology|April 26, 2016
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signallingDaniel E Croker, Peter N Monk, Reena Halai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2019
Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue FactorCaroline S Gravastrand, Bjørg Steinkjer, Bente Halvorsen, et al.
Nature Communications|October 6, 2016
Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degenerationRichard Gordon, Matthew L Neal, Jie Luo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegenerationTrent M Woodruff, James W Crane, Lavinia M Proctor, et al.
Archives of Pathology & Laboratory Medicine|January 1, 1997
Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer InstituteJ Albores-Saavedra, D Gersell, C B Gilks, et al.
Glia|October 10, 2019
The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteinsVandana Deora, John D Lee, Eduardo A Albornoz, et al.
Acta Neuropathologica|January 29, 2000
Schwann cell-onion bulb tumor of the trigeminal nerve: hyperplasia, dysplasia or neoplasia?S F LaPoint, J M Powers, J M Woodruff, et al.
Molecular Pharmacology|March 27, 2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activityDarren R March, Lavinia M Proctor, Martin J Stoermer, et al.
Pageof 45